PURPOSE
To compare source-to-background ratio (SBR)-based PET-CT auto-delineation with pathology in non-small-cell lung cancer (NSCLC) and to investigate whether auto-delineation reduces the… (More)
PURPOSE
To provide a comparison between radiotherapy with photons, protons and carbon-ions in the treatment of Non-Small-Cell Lung Cancer (NSCLC), performing a meta-analysis of observational studies.… (More)
PURPOSE
To evaluate the patterns of recurrence when elective node irradiation was omitted in patients with limited disease small cell lung cancer (LD-SCLC).
METHODS
A prospective phase II study was… (More)
Journal of clinical oncology : official journal…
2006
PURPOSE
To identify time factors for combined chemotherapy and radiotherapy predictive for long-term survival of patients with limited-disease small-cell lung cancer (LD-SCLC).
METHODS
A systematic… (More)
Journal of clinical oncology : official journal…
2010
PURPOSE
To derive recommendations for routine practice and clinical trials for techniques used in high-dose, high-precision thoracic radiotherapy for lung cancer.
METHODS
A literature search was… (More)
PURPOSE
The local site of relapse in non-small cell lung cancer (NSCLC) is primarily located in the high FDG uptake region of the primary tumour prior to treatment. A phase II PET-boost trial… (More)
PURPOSE
With this modeling study, we wanted to estimate the potential gain from incorporating fluorodeoxyglucose-positron emission tomography (FDG-PET) scanning in the radiotherapy treatment planning… (More)
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on… (More)
UNLABELLED
This study investigated the possibility of early response assessment based on (18)F-FDG uptake during radiotherapy with respect to overall survival in patients with non-small cell lung… (More)
Journal of clinical oncology : official journal…
2015
PURPOSE
Concurrent chemoradiotherapy with or without surgery are options for stage IIIA(N2) non-small-cell lung cancer. Our previous phase II study had shown the efficacy of induction chemotherapy… (More)